SCG5 and nonpapillary renal cell carcinoma: To the best of our knowledge, this is the first report indicating that JQ1 showed anti-cancer effects through downregulation of SCG5, SPOCD1, RGS19, and ARHGAP22. We also found that these genes were good independent predictors for OS in patients with ccRCC.